范式升维:心通医疗的心衰管理革命

器械之家
Dec 29, 2025

引言:成为心力衰竭诊断与治疗领域新兴科技领导者日前,微创心通与微创心律管理完成战略合并,后者正式成为前者的全资子公司。后续,二者将在统一的管理体系下协同运行,充分融合结构性心脏病领域的尖端器械治疗能力与心律管理领域的持续监测及数据洞察优势,全力进军前景广阔的心衰领域。基于深度整合双方的核心技术,微创心通旨在面向心衰全病因、覆盖病程全阶段的复杂诊疗需求,加速构建贯穿“监测-诊断-治疗-管理”全过程的...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10